Biocon Limited (NSE:BIOCON)
India flag India · Delayed Price · Currency is INR
370.95
+2.90 (0.79%)
Nov 12, 2026, 3:29 PM IST

Biocon Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
24,22424,16532,27112,33613,2356,630
Short-Term Investments
2,6437,7688,90710,24819,58520,501
Trading Asset Securities
-6,8984,4733,1564,4432,518
Cash & Short-Term Investments
26,86738,83145,65125,74037,26329,649
Cash Growth
-55.98%-14.94%77.35%-30.92%25.68%-8.03%
Accounts Receivable
60,59259,86854,87962,30635,73220,582
Other Receivables
-1,5509643891,3214,506
Receivables
60,59261,41855,84362,69537,05325,759
Inventory
71,45260,85749,31149,43942,43722,982
Prepaid Expenses
-2,4241,8991,5711,316873
Other Current Assets
21,1898,26810,15812,3475,2714,560
Total Current Assets
180,100171,798162,862151,792123,34083,823
Property, Plant & Equipment
148,767146,635134,141119,778101,22693,643
Long-Term Investments
10,59213,6476,8156,8438,6733,702
Goodwill
188,659183,775167,857163,724161,362264
Other Intangible Assets
105,141104,316102,719102,867105,25912,887
Long-Term Deferred Tax Assets
7,3355,5562,5773,1733,0102,933
Other Long-Term Assets
12,20110,77911,00212,53017,5586,688
Total Assets
652,795636,506587,973560,707520,428203,940

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
78,71367,72165,48762,72038,42016,085
Accrued Expenses
-11,8559,1312,9064,8401,741
Short-Term Debt
40,83240,78453,50127,97224,8028,962
Current Portion of Long-Term Debt
-----95
Current Portion of Leases
446724674547390211
Current Income Taxes Payable
2,9674,1601,7312,7692,2501,618
Current Unearned Revenue
-1,2771,4521,1761,9151,053
Other Current Liabilities
24,34814,17111,36255,49812,4908,515
Total Current Liabilities
147,306140,692143,338153,58885,10738,280
Long-Term Debt
110,269107,463124,054129,324152,90539,985
Long-Term Leases
5,4315,3705,3914,9242,0912,215
Long-Term Unearned Revenue
4,4864,8133,3663,1072,90112,151
Pension & Post-Retirement Benefits
-1,6091,2141,1011,034917
Long-Term Deferred Tax Liabilities
2,8492,4173,5773,9153,818523
Other Long-Term Liabilities
10,8947,92729,90812,00047,68415,169
Total Liabilities
281,235270,291310,848307,959295,540109,240

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
8,1488,1056,0036,0036,0036,003
Additional Paid-In Capital
-155,6002,5812,2851,7351,192
Retained Earnings
-141,798191,469177,906162,47669,890
Treasury Stock
--423-784-971-971-324
Comprehensive Income & Other
340,28035,23817,17112,6149,4267,564
Total Common Equity
348,428340,318216,440197,837178,66984,325
Minority Interest
23,13225,89760,68554,91146,21910,375
Shareholders' Equity
371,560366,215277,125252,748224,88894,700
Total Liabilities & Equity
652,795636,506587,973560,707520,428203,940

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
156,978154,341183,620162,767180,18851,468
Net Cash (Debt)
-130,111-115,510-137,969-137,027-142,925-21,819
Net Cash Growth
------
Net Cash Per Share
-84.54-84.40-115.15-114.49-119.51-18.24
Filing Date Shares Outstanding
1,6521,6201,1981,1971,1941,193
Total Common Shares Outstanding
1,6521,6201,1981,1971,1941,193
Working Capital
32,79431,10619,524-1,79638,23345,543
Book Value Per Share
210.91210.14180.66165.30149.6470.68
Tangible Book Value
54,62852,227-54,136-68,754-87,95271,174
Tangible Book Value Per Share
33.0732.25-45.19-57.45-73.6659.66
Land
-3,9033,7263,3732,9182,805
Buildings
-29,90026,49223,17020,81419,766
Machinery
-135,080120,289103,38997,26276,553
Construction In Progress
-46,12741,01739,85225,87534,203
Leasehold Improvements
-4,1583,6192,6862,518116